A Structured Review of Quantitative Models of the Pharmaceutical Supply Chain

Abstract

The aim of this review is to identify and provide a structured overview of quantitative models in the pharmaceutical supply chain, a subject not exhaustively studied in the previous reviews on healthcare logistics related mostly to quantitative models in healthcare or logistics studies in hospitals. The models are classified into three categories of classification: network design, inventory models, and optimization of a pharmaceutical supply chain. A taxonomy for each category is shown describing the principal features of each echelon included in the review; this taxonomy allows the readers to identify easily a paper based on the actors of the pharmaceutical supply chain. The search process included research articles published in the databases between 1984 and November 2016. In total 46 studies were included. In the review process we found that in the three fields the most common source of uncertainty used is the demand in the 56% of the cases. Within the review process we can conclude that most of the articles in the literature are focused on the optimization of the pharmaceutical supply chain and inventory models but the field on supply chain network design is not deeply studied.

A collaborative approach to maintaining optimal inventory and mitigating stockout risks during a pandemic: capabilities for enabling health-care supply chain resilience

“…4.1 The effect of a change in perception of uncertainty and risk on collaborative planning, forecasting and replenishment practices and optimal medical stock during a pandemic The COVID-19 pandemic introduces new perceptions of uncertainty and risk yet to be addressed by inventory management research outside of cost minimization, profit maximization and overall HCSC optimization (Franco and Alfonso-Lizarazo, 2017;Jabbarzadeh et al, 2019;Saha and Ray, 2019;da Conceição et al, 2020). Consistent with Townsend et al (2018), both industry and scholarly attempts to stretch uncertainty boundaries to cover growing unknowns increase the tendency for risk managers and researchers to conflate uncertainty with risk.…”

“…Most research on managing medical stocks was undertaken outside a pandemic context, and so highlight inventory management techniques that minimize cost, maximize profit, and generally optimize HCSCs through stochastic and periodic reviews, approximation of inventory control via simulation or radio frequency identification (RFID), or vendor-managed inventory (VMI) plans (Franco and Alfonso-Lizarazo, 2017; Jabbarzadeh et al ., 2019; Saha and Ray, 2019; da Conceição et al , 2020). However, in a pandemic context, optimized lean inventory systems are counterintuitive as governments, health-care and relief organizations individually grapple with clogged inventory processes.…”

Pharma 4.0: analysis on core competence and digital levelling implementation in pharmaceutical industry in Indonesia

“…The researchers contend that validity and reliability are critical to the quality of original research and strongly emphasize the data collection and analysis procedure ( Franco and Alfonso-Lizarazo, 2017 ; Probst et al., 2020b ). The prospect of reproducing the same results in subsequent research is reliability.…”

Price Cap Models in Pharmaceutical Online-to-Offline Supply Chains

“…In recent years, research related to pharmaceutical supply chains has received increasing attention from scholars [7,22,23]. Related papers are reviewed and summarized below.…”